A self-powered photoanode-supported photoelectrochemical immunosensor for CYFRA 21-1 detection based on InO/InS/CdInS heterojunction.

Biosens Bioelectron

Collaborative Innovation Center for Green Chemical Manufacturing and Accurate Detection, Key Laboratory of Chemical Sensing & Analysis in Universities of Shandong, School of Chemistry and Chemical Engineering, University of Jinan, Jinan, 250022, PR China; State Key Laboratory of Analytical Chemistry for Life Science, Department of Chemistry, Nanjing University, Nanjing, 210023, China. Electronic address:

Published: December 2020

A self-powered photoanode-supported photoelectrochemical (PEC) immunosensor was designed based on InO/InS/CdInS as photoanode and PDA@CNTs as biocathode for the detection of CYFRA 21-1. In this proposal, InO/InS/CdInS heterojunction modified indium-tin oxide (ITO) electrode was served as a substitute for platinum (Pt) counter electrode to provide an evident and stable photocurrent signal. The matched band structure of InO, InS and CdInS as well as the unique hollow porous structure of InO/InS/CdInS played a pivotal role in accelerating the separation and transfer of photocarrier. Meanwhile, PDA@CNTs with excellent conductivity further enhanced the photocurrent which was provided by photoanode InO/InS/CdInS heterojunction. Besides, PDA could effectively capture the antibody (Ab) through Michael addition. Separating photoanode from the sensing biocathode was conducive to improve the anti-interference capability of PEC sensor because the reductive species in biologic media will change PEC properties of the photoanode interface. Under optimal conditions, the PEC immunosensor have realized the detection of CYFRA 21-1 (0.5 pg/mL - 50 ng/mL) and the detection limitation with 0.16 pg/mL. In addition, the proposed self-powered PEC sensor with acceptable selectivity, reproducibility, and stability provide a new horizon for designing PEC immunosensing platform in bioassays.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bios.2020.112580DOI Listing

Publication Analysis

Top Keywords

cyfra 21-1
12
ino/ins/cdins heterojunction
12
self-powered photoanode-supported
8
photoanode-supported photoelectrochemical
8
based ino/ins/cdins
8
pec immunosensor
8
detection cyfra
8
pec sensor
8
pec
6
ino/ins/cdins
5

Similar Publications

Objective: Urinary proteins are effective tumor biomarkers. Human epididymis protein 4 (HE4), progastrin-releasing peptide (ProGRP), carcinoembryonic antigen (CEA), cytokeratin-19 fragment 21-1(CYFRA 21-1), and neuron-specific enolase (NSE) in serum, were proposed as tumor biomarkers of lung cancer. Our aim was to identify the urine protein biomarkers that can distinguish patients with lung cancer from healthy individuals and/or patients with benign lung disease with a high level of sensitivity and specificity.

View Article and Find Full Text PDF

BiS/BiO(OH) nanorods with internal electric field throughout the entire bulk phase as photoelectrochemical sensing platforms for CYFRA21-1 immunoassay.

Anal Chim Acta

February 2025

Key Laboratory of Chemical Sensing & Analysis in Universities of Shandong, School of Chemistry and Chemical Engineering, University of Jinan, 250022, Jinan, PR China; Department of Chemistry, Sungkyunkwan University, 16419, Suwon, Republic of Korea. Electronic address:

Photoelectrochemical (PEC) immunosensors are highly promising tools for monitoring biochemical molecules. Constructing high-performance heterojunctions is a general method to improve the sensitivity of PEC immunosensors. The internal electric field (IEF) formed at the heterojunction interface plays a crucial role in coordinating the separation of photogenerated carriers.

View Article and Find Full Text PDF

Bladder cancer (BC) is known for its high recurrence rate and requires constant patient monitoring. To confirm the diagnosis, a tissue sample from a cystoscopy is required, which the patient often avoids. Urine has the potential to be utilized as a diagnostic fluid because of its non-invasive nature and various biomarker contents.

View Article and Find Full Text PDF

Repurposing bosentan as an anticancer agent: EGFR/ERK/c-Jun modulation inhibits NSCLC tumor growth.

Fundam Clin Pharmacol

February 2025

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.

Drug repurposing of well-established drugs to be targeted against lung cancer has been a promising strategy. Bosentan is an endothelin 1 (ET-1) blocker widely used in pulmonary hypertension. The current experiment intends to inspect the anticancer and antiangiogenic mechanism of bosentan targeting epidermal growth factor receptor (EGFR) /extra-cellular Signal Regulated Kinase (ERK) /c-Jun/vascular endothelial growth factor (VEGF) carcinogenic pathway.

View Article and Find Full Text PDF

This study investigates the prognostic value of serum biomarkers PD-L1 and IGFBP-2 in patients with esophageal carcinoma. It finds a significant positive correlation between these biomarkers and established tumor markers CEA and CYFRA21-1. The 3-year survival rate for the patient cohort was 45.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!